During the past decade, Geisinger Woodbine conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Geisinger Woodbine" are "Anesthesia" (1 trials), "Arm Fracture" (1 trials), "Concussion, Brain" (1 trials), "Distal Radius Fracture" (1 trials) and "Opioid Use" (1 trials). Many other conditions were trialed in "Geisinger Woodbine" in a lesser frequency.

Most popular intervention types in "Geisinger Woodbine" are "Drug" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Betadine" (1 trials), "Chlorhexidine" (1 trials), "Dexamethasone" (1 trials), "Liposomal bupivacaine" (1 trials) and "Methylprednisolone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Geisinger Woodbine" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Geisinger Woodbine". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Geisinger Woodbine, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Geisinger Woodbine, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".